Advertisement
Science Award – February 18, 2025
Miriam Merad is awarded the Sjöberg Prize, worth USD one million, for her discovery of new targets for cancer therapies in the immune system.
Intellectual Property – February 18, 2025
Dignitana has received a Notice of Allowance from the Korean Intellectual Property Office for a patent titled “Scalp Cooling Apparatus, Method and System.”
Financing – February 17, 2025
AlzeCure Pharma’s project NeuroRestore ACD856 has received EUR 2.5 million from the EU’s European Innovation Council.
Biotech Business – February 14, 2025
The Finnish biotech company developing stem cell therapies for vision restoration, has raised funding from Voima Ventures, Finnish family offices (Stephen Industries Inc. & Biothom Oy), private investors, and Business Finland.
Biotech Business – February 14, 2025
The decision is in line with Aqilion’s strategy to focus the business to the internal pipeline programs within chronic inflammation.
Collaboration – February 12, 2025
The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), a USD 50 million investment that will focus on combatting antimicrobial resistance (AMR) caused by a specific range of bacteria that are among the leading contributors to AMR-associated deaths.
Advertisement
Clinical Trials – January 29, 2025
Herantis Pharma has announced an update of the ongoing Phase 1b clinical trial of HER-096.
Clinical Trials – January 14, 2025
Orexo has announced positive topline results from the clinical study OX640-002.
Clinical Trials – December 18, 2024
Hansa Biopharma has announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome (GBS) and an indirect treatment comparison of the 15-HMedIdeS-09 study data to the International Guillain-Barré Syndrome Outcome Study (IGOS), a worldwide prospective study by the Inflammatory Neuropathy Consortium on prognosis and biomarkers of GBS.
Clinical Trials – December 11, 2024
Immunovia has announced the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer) to detect early-stage pancreatic ductal adenocarcinoma (PDAC).
Clinical Trials – December 10, 2024
The first dose has been administered in the company’s Phase II clinical study evaluating the drug candidate sevuparin for the treatment of chronic kidney disease (CKD) with associated anemia.
Clinical Trials – December 3, 2024
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment.
Pharma Business – February 12, 2025
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
Acquisition – February 10, 2025
Pharming Technologies declares unconditional and completes the recommended cash offer to the shareholders of Abliva and extends the acceptance period.
New Market – February 10, 2025
Boule Diagnostics has entered into an exclusive distribution agreement with VitalScientific for the US market.
Acquisition – February 7, 2025
Mayumana Healthcare is a specialist distributor of medical equipment and related supplies in the Netherlands.
Agreement – February 3, 2025
“We are thrilled to announce this strategic partnership with a top-tier medical school in clinical and radiological research. This is a critical step toward our vision of developing multiple products within data quality and liver disease management,” says Gerald Pötzsch, CEO of ContextVision.
MedTech Business – February 3, 2025
The US Food and Drug Administration (FDA) has granted clearance for the surgical device SutureTOOL.
Biotech Business – February 11, 2025
Abera Bioscience reports that its first in vivo study with a novel nasal influenza vaccine candidate has delivered promising results in the mouse model.
Biotech Business – February 5, 2025
The company has resumed development of the its TAK1 program as the company has regained the control and ownership of the program.
Biotech Business – February 4, 2025
The funding round was led by new investors Fåhraeus Startup and Growth (FSG), a Nordic venture capital fund, and European Innovation Council (EIC) Fund.
Science article – February 7, 2025
Researchers at Linköping University have succeeded in creating a close connection between individual cells and organic electronics.
Science Award – January 30, 2025
The Crafoord Prize in Polyarthritis 2025, worth SEK six million, is awarded to Christopher Goodnow, Australia, and David Nemazee, USA.
Science News – January 16, 2025
A new international study led by researchers at Karolinska Institutet shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images.
BHS Logistics
BHS Logistics is a modern transport company focused on the customers’ wishes and needs for large capacity and flexibility, as well as the secure storage, handling, and transport of goods.
Eltronic A/S
Eltronic A/S is Denmark’s leading automation company, with over 25 years of experience in implementing production systems and automation solutions. The company’s goal is to be the preferred partner for its customers while enhancing their global competitiveness and sustainability.
Scandinavian CRO
Scandinavian CRO is in an exciting expansion phase, and we’re looking for a new Business Development (BD) Manager to strengthen our team.
Stryker
As Territory Sales Manager, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s Trauma medical devices, covering the Oslo region & Østlandet.
BÜCHI Labortechnik
The Company BÜCHI Labortechnik AG with headquarters in Flawil, Switzerland, is a leading provider of laboratory technology solutions for R&D, quality control and production worldwide. Established in 1939, BUCHI serves diverse industries such as pharmaceuticals, chemicals, food & beverage, feed, environmental analysis and academia. BÜCHI Labortechnik GmbH is a fully owned subsidiary of BÜCHI Labortechnik […]
Burner International
The Company Burner has been developing and manufacturing the original unbeatable Fire starters since 1992, when the company BURNER International A/S was founded in Denmark. Management and production remain in Denmark, ensuring the consistent delivery of high-quality products that comply with international ethical standards in retail trade (code of conduct). You will find the Burner […]
In a new job – February 10, 2025
“It is a great advantage for me to have her by my side in the continued development of Oxcia and the technology platform, O2-DDR,” emphasizes Oxcia’s CEO, Ulrika Warpman Berglund.
In a new job – February 7, 2025
The Board of Directors, in discussion with CEO, Göran Forsberg, has decided to initiate a search for a new CEO to lead Cantargia into the next phase of development and value creation.
In a new job – February 2, 2025
Knut and Alice Wallenberg Foundation’s strategic programs are comprehensive investments in basic research and postgraduate education in areas that the Foundation considers to be of great importance for Sweden’s development.
Careers article – January 9, 2025
Getting back to work after a long and relaxing holiday can be quite hard. Here is some advice to make things easier.
Biotech Business – December 3, 2024
Alligator Bioscience is sharpening its primary focus on its lead asset mitazalimab, and, given current capital restraints, plans to adjust the size of its organization and scope of operations to reflect that.
Biotech Business – November 26, 2024
The rightsizing is expected to result in redundancy of approximately 20 percent of the employees across the CELLINK organization.
Profiles in Business – February 13, 2023
Iris Öhrn considers herself a cosmopolitan person, and with good reason. The investment advisor for life science at Business Region Göteborg left her native Cuba to study and work abroad before settling in Sweden. While up until recently, most of Iris Öhrn’s goals were professional, now she is seeking to have more of an impact […]
Profiles in Business – December 16, 2021
An adventurous spirit rooted in a Viking heritage and her parents’ as an example helped spur Gitte Pedersen to move from her native Denmark to the U.S. 20 years ago, where she helped create a company and made a home. CEO and co-founder of Genomic Expression in Massachusetts, USA, Gitte Pedersen also credits her mother […]
Profiles in Business – December 15, 2019
Business woman Barbro Ehnbom has become renowned for her valuable networks and her successful business-generating activities and within life sciences she is perhaps best known as the founder of SALSS, the Swedish-American Life Science Summit.
This site uses cookies
